ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings

Benzinga Earnings

08/07

ICU Medical Inc (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.

The company reported quarterly earnings of $2.37 per share which beat the analyst consensus estimate of $1.91 per share. The company reported quarterly sales of $551.700 million which beat the analyst consensus estimate of $533.428 million.

ICU Medical raised its FY2026 adjusted EPS guidance from $7.75-$8.45 to $8.60-$9.00.

Vivek Jain, ICU Medical’s Chief Executive Officer, said, “Second quarter results were ahead of our expectations for Infusion Systems and generally in line with expectations for the remainder of the business.”

ICU Medical shares rose 4.8% to $174.28 in pre-market trading.

These analysts made changes to their price targets on ICU Medical following earnings announcement.

Needham analyst Mike Matson maintained the stock with a Buy and raised the price target from $165 to $187.
BTIG analyst Sam Eiber maintained the stock with a Buy and raised the price target from $170 to $200.

Considering buying ICUI stock? Here’s what analysts think:

Photo via Shutterstock

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2657561732"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2657561732\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2657561732?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-07 18:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2657561732","market":"hk","top_or_hot":-1,"title":"ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings","media":"Benzinga Earnings","content":"<html><body><p><strong>ICU Medical Inc</strong> (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.</p>\n<p>The company reported quarterly earnings of $2.37 per share which beat the analyst consensus estimate of $1.91 per share. The company reported quarterly sales of $551.700 million which beat the analyst consensus estimate of $533.428 million.</p>\n<p>ICU Medical raised its FY2026 adjusted EPS guidance from $7.75-$8.45 to $8.60-$9.00.</p>\n<p>Vivek Jain, ICU Medical’s Chief Executive Officer, said, “Second quarter results were ahead of our expectations for Infusion Systems and generally in line with expectations for the remainder of the business.”</p>\n<p>ICU Medical shares rose 4.8% to $174.28 in pre-market trading.</p>\n<p>These analysts made changes to their price targets on ICU Medical following earnings announcement.</p>\n<ul>\n<li>Needham analyst Mike Matson maintained the stock with a Buy and raised the price target from $165 to $187.</li>\n<li>BTIG analyst Sam Eiber maintained the stock with a Buy and raised the price target from $170 to $200.</li>\n</ul>\n<p><strong>Considering buying ICUI stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"321\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189-1024x321.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189-1024x321.png 1024w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189-300x94.png 300w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189-768x241.png 768w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189.png 1153w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time\">2026-08-07 18:43</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong>ICU Medical Inc</strong> (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.</p>\n<p>The company reported quarterly earnings of $2.37 per share which beat the analyst consensus estimate of $1.91 per share. The company reported quarterly sales of $551.700 million which beat the analyst consensus estimate of $533.428 million.</p>\n<p>ICU Medical raised its FY2026 adjusted EPS guidance from $7.75-$8.45 to $8.60-$9.00.</p>\n<p>Vivek Jain, ICU Medical’s Chief Executive Officer, said, “Second quarter results were ahead of our expectations for Infusion Systems and generally in line with expectations for the remainder of the business.”</p>\n<p>ICU Medical shares rose 4.8% to $174.28 in pre-market trading.</p>\n<p>These analysts made changes to their price targets on ICU Medical following earnings announcement.</p>\n<ul>\n<li>Needham analyst Mike Matson maintained the stock with a Buy and raised the price target from $165 to $187.</li>\n<li>BTIG analyst Sam Eiber maintained the stock with a Buy and raised the price target from $170 to $200.</li>\n</ul>\n<p><strong>Considering buying ICUI stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"321\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189-1024x321.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189-1024x321.png 1024w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189-300x94.png 300w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189-768x241.png 768w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189.png 1153w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ICUI","symbol_name":"ICU医疗","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/08/61032699/icu-medical-analysts-boost-their-forecasts-following-upbeat-q2-earnings","article_id":"2657561732","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2657561732","pubTimestamp":1786099412,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga Earnings","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"\nICU Medical Inc (NASDAQ:ICUI) reported strong Q2 earnings of $2.37 per share and raised its FY2026 guidance. Analysts have increased price targets for the stock.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ICUI":"ICU医疗","ICU":"SeaStar Medical Holding Corporation"},"translate_title":"第二季度盈利乐观后，ICU Medical 分析师上调了预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ICU":1.5,"ICUI":1.5},"content_text":"ICU Medical Inc (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.\nThe company reported quarterly earnings of $2.37 per share which beat the analyst consensus estimate of $1.91 per share. The company reported quarterly sales of $551.700 million which beat the analyst consensus estimate of $533.428 million.\nICU Medical raised its FY2026 adjusted EPS guidance from $7.75-$8.45 to $8.60-$9.00.\nVivek Jain, ICU Medical’s Chief Executive Officer, said, “Second quarter results were ahead of our expectations for Infusion Systems and generally in line with expectations for the remainder of the business.”\nICU Medical shares rose 4.8% to $174.28 in pre-market trading.\nThese analysts made changes to their price targets on ICU Medical following earnings announcement.\n\nNeedham analyst Mike Matson maintained the stock with a Buy and raised the price target from $165 to $187.\nBTIG analyst Sam Eiber maintained the stock with a Buy and raised the price target from $170 to $200.\n\nConsidering buying ICUI stock? Here’s what analysts think:\n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}